Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-21-132481

Options or other derivatives

  • Chief Scientific Officer acquired 243,639 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sethuraman Natarajan · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-10-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +243,639 $20.00 2031-10-28 243,639 243,639 D
Loading xslF345X03/tm2131250-14_4seq1.xml…